The Briefing: Pepperdine’s Trademark Claim Against Netflix in “Running Point” Case Goes Under For Good
Episode 421 -- The Dangers of AI Mistakes
EEO-1 Reports, Remote Work, and Non-Compete Restrictions in Tennessee - Employment Law This Week®
The Briefing: UMG v. Quince: When Trending Audio Becomes Copyright Infringement
Unexpected Paths to IP Law with Kevin MacDonald
New Preorder Patent Owner Rights in Ex Parte Reexamination — Patents: Post-Grant Podcast
The Briefing: Documentary Fair Use After Warhol: The Tenth Circuit Gets It Right
Words Matter: How to Draft Arbitration Agreements That Hold Up in Court - Employment Law This Week®
SkadBytes Podcast | AI Regulation: EU and UK Update and What It Means in Practice
The Briefing: Frida Kahlo vs. The 11th Circuit - A Warning for IP Owners Everywhere
Navigating ICE’s Updated I-9 Audit Guidelines: What Employers Need to Know
At the Intersection of Biotech and AI with Janice Vatland
Podcast - De genérica a icónica: El glow up de una marca
JONES DAY PRESENTS®: Cross-Border Trade Secret Litigation in the U.S. Courts
How Did James Bond Spark a 50-Year Legal War Over Who Owns 007? — No Infringement Intended Podcast
Episode 406 -- AI Risks and Compliance: Building a Governance Framework
The Briefing: Taylor Swift, Trademark Law, and the Fight Over ‘Life of a Showgirl’
DOJ’s Bulk Sensitive Data Transfer Rule: Key Insights for Health Care Compliance Teams – Diagnosing Health Care
SBR-Author’s Podcast: Bribery Beyond Borders: The Hidden History and Future of the FCPA with Severin Wirz
'Urgent National Action to Save College Sports': Trump’s NIL Playbook — Highway to NIL Podcast
The US Court of Appeals for the Federal Circuit reversed a judgment awarding damages and a permanent injunction, finding that the plaintiff’s trade secret misappropriation claims were barred by the statute of limitations...more
Addressing patent eligibility and attorneys’ fees, the US Court of Appeals for the Federal Circuit affirmed a district court’s ruling that five farming data patents were directed to patent-ineligible subject matter, but...more
Addressing when a copyright ownership claim accrues under the Copyright Act, the US Court of Appeals for the Sixth Circuit reversed a summary judgment grant, finding that genuine disputes of material fact remained as to...more
In most commercially significant inventions, strategic filing of various types of “child” patent applications (patent applications extending from an original or “parent” patent application) in various worldwide jurisdictions...more
This article catalogs the principal categories of risk that corporate counsel should evaluate, with concrete examples and an eye toward the contract levers that can mitigate each one. Data is the fuel for AI systems, and the...more
In a decision that, in retrospect, is not surprising (in view of the haste with which the Court took up the case after granting certiorari; see “Solicitor General Proves Persuasive; Supreme Court Grants Hikma’s...more
The Trademark Trial and Appeal Board (“TTAB” or “the Board”) afforded no weight to a bare-bones trademark consent agreement that contained no provisions for the parties to avoid confusion, even though the same agreement had...more
What You Need to Know Unfair competition claims arise when a business alleges that a competitor, former employee, or business partner has engaged in improper conduct that damages its goodwill, customer relationships, or...more
The U.S. Court of Appeals for the Federal Circuit held that trade secret plaintiffs may seek unjust enrichment damages measured by a defendant's gains from misappropriated technology and ordered a new trial on trade secret...more
On June 4, 2026, a unanimous Supreme Court in Hikma Pharms. USA Inc. v. Amarin Pharma, Inc., No. 24-889, clarified the standard for pleading induced patent infringement under 35 U.S.C. § 271(b). ...more
On June 3, 2026, Xbrane announced the resubmission of its aBLA for Xlucane (ranibizumab), a proposed biosimilar of Genentech’s Lucentis® (ranibizumab) after receiving a second Complete Response Letter (CRL) from the FDA in...more
On June 4, 2026 in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., the U.S. Supreme Court issued a unanimous decision that materially recalibrates inducement analysis in the context of Section viii carve-outs....more
The United States Patent and Trademark Office (USPTO) has launched a new pilot program introducing an informational “Pre-Docketing Notice” for pending utility nonprovisional patent applications. This initiative is designed to...more
On June 2, 2026, the White House issued an executive order (EO) titled Promoting Advanced Artificial Intelligence Innovation and Security, establishing a federal policy framework that prioritizes AI-driven cybersecurity while...more
The Eleventh Circuit’s recent decision in Lil’Joe Records, Inc. v. Ross et al., Case No. 24-13978 (11th Cir. June 2, 2026), reminds bankruptcy attorneys of the importance of scheduling and dealing with all of a debtor’s...more
In the Public Interest is excited to present the new miniseries, “AI In the Public Interest.” These episodes will examine AI’s impact on the legal landscape and its broader implications for the day-to-day operations of...more
Inventions conceived or reduced to practice during the performance of work funded by the U.S. federal government are subject to various obligations under the Bayh-Dole Act. Fulfilling these obligations is important to...more
On May 18, 2026, USPTO Director John Squires and Deputy Director Coke Morgan Stewart held a “listening session” with intellectual property practitioners, academics, and other industry professionals to discuss potential...more
When fans think about the FIFA World Cup, they picture the matches, the players, the national pride, the fan festivals, and the extraordinary global energy surrounding the tournament. What they rarely see, however, is the...more
Background - In a precedential Director discretionary denial issued May 14, 2026, USPTO Director John A. Squires denied institution of inter partes review in Magnolia Medical Technologies, Inc. v. Kurin, Inc., holding that...more
Our Intellectual Property Group examines a Federal Circuit decision that strengthens the case for software and network-based patents whose claims are grounded in specific technical solutions rather than framed as abstract...more
While the legal landscape is continuing to take shape, a number of recent court decisions indicate that unlicensed use of copyrighted data to train AI models generally constitutes fair use. Each fair use inquiry depends on...more
Despite periodic mentions by aerospace innovators of “secret patents,” this author is not aware of any evidence of such patents. There may be confusion with “Secrecy Orders,” which apply to patent applications, but not to...more
The measurement of the hydrogen ion concentration in an aqueous solution is represented (on a logarithmic scale) as the pH, wherein water under ambient conditions (a temperature of 25°C) has a neutral pH of 7 and the solution...more
You built something real. Now you want to get paid: whether through acquisition, fundraise, or IPO. But a few preventable mistakes can crater your valuation or kill a deal entirely. Here’s what to lock down before anyone runs...more